Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

BARDA - ASPR / DAAPPO / BARDA DCMA

Contract Value

Not provided

Codes & Classification
Solicitation Number

BARDA-FY27-10192026

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing

Classification Code

6525

Additional Details
Set Aside

NONE

Place of Performance

Washington, Missouri, UNITED STATES

SourceSAM
Documents2
The Center for Biomedical Advanced Research and Development Authority (BARDA), operating under the U.S. Department of Health and Human Services (HHS) and the Office of the Assistant Secretary for Preparedness and Response, has issued a Sources Sought Notice (SSN) titled "Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection." This notice, identified by procurement number BARDA-FY27-10192026, is intended for planning purposes and does not constitute a solicitation for contract award. BARDA seeks to gather information from industry stakeholders regarding current and emerging technologies that support rapid, automated ultrasound-based detection of musculoskeletal injuries—specifically fractures and soft tissue injuries—using advanced Super Intelligence (SI) capabilities, formerly referred to as Artificial Intelligence (AI). **Purpose and Scope** The primary objective of this SSN is to identify innovative medical countermeasure technologies that can facilitate rapid triage and diagnosis of musculoskeletal injuries in a variety of settings, including emergency departments, urgent care centers, field environments, and disaster response scenarios. The focus is on standalone, point-of-care ultrasound devices equipped with SI-enabled image processing and diagnostic capabilities. These devices are intended to improve the speed, accuracy, and accessibility of fracture detection at the point of injury, especially in situations where traditional imaging modalities such as radiography and CT scans are unavailable or impractical. BARDA is interested in understanding the marketplace for such devices, including current and forecasted prices, inventories, manufacturing capabilities, and supply chain resilience. The information collected will inform future acquisition strategies, which may include device purchases, leases, and vendor-managed inventory (VMI) arrangements, with the goal of enhancing national preparedness for mass casualty events and other emergencies involving traumatic injuries. **Key Requirements and Expected Deliverables** Respondents are requested to provide detailed capability statements addressing the following technical and business criteria: - **Display and Diagnostic Capability:** Devices must offer automated ultrasound imaging-based volumetric capture and display of anatomical structures, with SI/ML models trained to assist in bone detection and identification (e.g., wrist, ankle). The models should be validated against independent datasets and demonstrate performance superior to human imaging experts. Devices should distinguish fracture types and severity, detect edema or soft tissue injuries, and render 3D-rotatable models with color overlays for clinician adjudication. Performance data comparing the device to standard radiographic and CT imaging is required. - **Device Design and Portability:** The solution should be a standalone, ruggedized, point-of-care unit with integrated SI-processing, suitable for field deployment. All necessary supplies (imaging media, gels, wipes) should be included in a portable unit. Battery life and power requirements must support use in austere environments. Devices should enable data export and integration with electronic health record (EHR) systems for billing and documentation. - **Use-Case Flexibility:** Devices must operate effectively in both field and clinical settings, require minimal training for non-specialist operators (e.g., first responders, medics), function independently of network connectivity, and be compatible with hospital and urgent care workflows, including mass casualty triage. - **Development Status and Regulatory Maturity:** Respondents should summarize their development pathway, including preclinical and clinical testing, regulatory status (e.g., FDA 510k clearance, breakthrough designation), and any relevant work with federal agencies. Key technical risks and mitigation strategies should be outlined. - **Scalability and Supply Chain Resilience:** Information on U.S. domestic manufacturing capacity, inventory management, quality systems (GMP, ISO), supply chain resilience for critical components, and cybersecurity/data management standards is required. Respondents should demonstrate their ability to handle sensitive patient information securely and integrate with EHR systems. - **Indicated Population and Use Cases:** Devices should be applicable across adult and pediatric populations, suitable for blast injuries, blunt trauma, structural collapse, and mass casualty scenarios, with demonstrated or anticipated performance across various fracture types and anatomical locations. **Contracting Entity and Location** The contracting entity is BARDA - ASPR / DAAPPO / BARDA DCMA, a federal office within HHS. The place of performance is Washington, Missouri (MO), United States. The relevant classification codes are NAICS 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing, 2022 version) and Product Service Code 6525. **Procurement Type and Set-Aside** This is a Sources Sought Notice, not a solicitation for contract award. There are no set-aside requirements; responses are sought from both small businesses and other than small businesses. Respondents must identify their business size status under the specified NAICS code. **Response Instructions and Contact Information** Interested parties must submit their capability statements and supporting materials in Microsoft Office® or Adobe® Acrobat® format via email to Richard Hall ([email protected]) and Justin Moore ([email protected]) by 1:00 p.m. Eastern Time on November 18, 2026. All questions or concerns should be directed to the same contacts. Responses should be concise, not exceeding 10 single-sided pages per technical and business section, and formatted in 12-point Times New Roman font. **Constant Elements Over Contract Lifecycle** The foundational context for this notice is rooted in national preparedness and response frameworks, including the Project BioShield Act of 2004, the Pandemic and All-Hazards Preparedness Act of 2006, and the National Health Security Strategy 2023–2026. The focus on medical countermeasures for CBRN threats and mass casualty events will remain central throughout any subsequent procurement activity. The requirement for robust, portable, SI-enabled ultrasound devices that enhance fracture detection and triage capabilities in diverse settings is a constant, as is the emphasis on regulatory compliance, manufacturing scalability, and supply chain resilience. **Summary for Contractors** Contractors with expertise in developing, manufacturing, and deploying advanced ultrasound devices with integrated SI capabilities for fracture detection are encouraged to respond. The opportunity aligns with organizations possessing strong technical, regulatory, and manufacturing competencies, particularly those able to support rapid deployment and integration in both clinical and field environments. The notice provides a comprehensive framework for evaluating the suitability of technologies and business models for future acquisition planning by BARDA. For further details and to access the notice, visit: [SAM.gov Opportunity ID 6760a50a38a24412868d95e27524d594](https://sam.gov/opp/6760a50a38a24412868d95e27524d594/view).